Akoya Biosciences Inc (AKYA)
2.62
-0.11
(-4.03%)
USD |
NASDAQ |
Nov 04, 16:00
2.62
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Gross Profit Margin (Quarterly): 57.79% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 57.79% |
| March 31, 2024 | 45.66% |
| December 31, 2023 | 62.75% |
| September 30, 2023 | 60.58% |
| June 30, 2023 | 51.51% |
| March 31, 2023 | 57.42% |
| December 31, 2022 | 56.77% |
| September 30, 2022 | 57.86% |
| June 30, 2022 | 57.79% |
| Date | Value |
|---|---|
| March 31, 2022 | 59.76% |
| December 31, 2021 | 63.29% |
| September 30, 2021 | 62.73% |
| June 30, 2021 | 62.23% |
| March 31, 2021 | 60.64% |
| December 31, 2020 | 61.26% |
| September 30, 2020 | 60.62% |
| June 30, 2020 | 61.57% |
| March 31, 2020 | 60.76% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
45.66%
Minimum
Mar 2024
63.29%
Maximum
Dec 2021
58.94%
Average
60.60%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 48.03% |
| Azenta Inc | 39.96% |
| Harvard Bioscience Inc | 57.23% |
| Bionano Genomics Inc | 33.26% |
| Singular Genomics Systems Inc | -24.15% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -124.4% |
| Return on Assets | -35.71% |
| Return on Invested Capital | -50.59% |
| Profit Margin (Quarterly) | -56.76% |
| Operating Margin (Quarterly) | -47.47% |
| Return on Net Operating Assets | -66.97% |